Clinical Trial News and Research

RSS

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state's stem cell agency.

31 Oct 2019

UCLA prostate cancer program receives $8.7 million grant from NCI

The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.

31 Oct 2019

Doctors report first death from fecal microbiota transplant

Details of an investigational study have emerged after a man died following a fecal microbiate transplant. The events prompted the FDA to set new safety guidelines for the practice.

31 Oct 2019

Researchers identify genes linked to most severe symptoms of multiple sclerosis

In a bid to determine factors linked to the most debilitating forms of multiple sclerosis, Johns Hopkins Medicine researchers say they have identified three so-called "complement system" genes that appear to play a role in MS-caused vision loss.

From Johns Hopkins Medicine 31 Oct 2019

Research forum to present results of novel anti-obesity medications

Rhythm Pharmaceuticals and Novartis will present findings from the latest stages of clinical evaluation of new anti-obesity medications during a special late-breaking research forum titled "Emerging Pharmacological Anti-obesity Therapies."

31 Oct 2019

Researchers develop new therapeutic concept for treatment of temporal lobe epilepsy

Teams of researchers from Charité - Universitätsmedizin Berlin and the Medical University of Innsbruck have developed a new therapeutic concept for the treatment of temporal lobe epilepsy.

30 Oct 2019

Beckman Coulter receives BARDA funding to develop novel sepsis detection algorithm

Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.

From Beckman Coulter Diagnostics 30 Oct 2019

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

November is National Pancreatic Cancer Awareness month. This year alone, more than 56,000 Americans will be diagnosed with pancreatic cancer. Pancreatic tumors are particularly aggressive and hard to treat "due to a mutational profile that makes it resistant to therapies that work better for other tumor types," explains Angela Alistar, MD, medical director of GI Oncology at Morristown Medical Center.

30 Oct 2019

New TB vaccine: mid-phase trials confirm safety, long-term prevention

A new study published on October 29, 2019, in the New England Journal of Medicine, reports a new vaccine which could change the face of tuberculosis prevention. The disease kills 1.5 million people worldwide each year.

30 Oct 2019

IU researcher receives NIH grant to perform clinical trial on cirrhosis

An Indiana University School of Medicine researcher has been awarded a five-year, $1.8 million grant from the National Institutes of Health for a clinical trial, aimed at providing new avenues to improve liver function for patients with alcoholic cirrhosis.

30 Oct 2019

New study could lead to personalized treatment for debilitating autoimmune condition

A new study has shed light on a debilitating autoimmune condition by identifying a number of subtypes of the disease which could lead to personalised treatment for patients.

29 Oct 2019

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Atlantic Health System is treating patients in a new Phase 2 clinical trial of CAR T-cell therapy at Morristown Medical Center. A select number of sites across the U.S. are involved in this study, which is done on an outpatient basis.

25 Oct 2019

Enhanced informatics tool could help better identify nonfatal opioid overdose cases in the ED

A team of researchers at the Medical University of South Carolina has been awarded $3.75 million by the National Center for Advancing Translational Sciences to enhance an existing informatics tool known as "informatics for integrating biology and the bedside" or I2B2.

24 Oct 2019

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Infant formula containing MFGM contributes to beneficial cognitive, respiratory health outcomes

Results from a clinical trial published today in the Journal of Pediatrics show infants who consume formula containing milk fat globule membrane (MFGM) -- a complex layer that normally surrounds fat in milk -- score higher in tests of cognitive, language and motor development by their first birthdays than infants consuming a milk-based formula that didn't contain MFGM.

24 Oct 2019

NIA-funded study to examine overall benefits and risks of statins in older adults

The National Institute on Aging has funded a major study to examine the overall benefits and risks of cholesterol-lowering drugs known as statins in adults age 75 or older without cardiovascular disease.

23 Oct 2019

UAB researchers awarded grant to study a vaccine for gonorrhea

University of Alabama at Birmingham researchers have been awarded a three-year contract with a total potential amount of $10 million to study the efficacy of the vaccine Bexsero - already licensed to prevent meningitis - in protecting vulnerable populations from infection with the bacteria that causes gonorrhea.

23 Oct 2019

Clinical Trial News and Research

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

UCLA prostate cancer program receives $8.7 million grant from NCI

Doctors report first death from fecal microbiota transplant

Researchers identify genes linked to most severe symptoms of multiple sclerosis

Research forum to present results of novel anti-obesity medications

Researchers develop new therapeutic concept for treatment of temporal lobe epilepsy

Beckman Coulter receives BARDA funding to develop novel sepsis detection algorithm

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

New TB vaccine: mid-phase trials confirm safety, long-term prevention

IU researcher receives NIH grant to perform clinical trial on cirrhosis

New study could lead to personalized treatment for debilitating autoimmune condition

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Enhanced informatics tool could help better identify nonfatal opioid overdose cases in the ED

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

Infant formula containing MFGM contributes to beneficial cognitive, respiratory health outcomes

NIA-funded study to examine overall benefits and risks of statins in older adults

UAB researchers awarded grant to study a vaccine for gonorrhea

SLU research halts toxic protein linked to muscular dystrophy in animal models

Therapy for common vision disorder fails to improve children's reading test scores

Study finds little evidence on effectiveness of common antidepressant in autism spectrum disorders

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer